Residency · Orange, CA
Sponsored by University of California (Irvine)
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1.
Autophagy · 2021 · 2,291 citations · Albert La Spada
Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort Trial.
JAMA oncology · 2023 · 399 citations · Daniela Bota
Phase I trial of hES cell-derived dopaminergic neurons for Parkinson's disease.
Nature · 2025 · 114 citations · Claire Henchcliffe
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study.
The Lancet. Neurology · 2023 · 231 citations · Ali Habib
Single-nucleus chromatin accessibility and transcriptomic characterization of Alzheimer's disease.
Nature genetics · 2021 · 537 citations · Mari Perez-Rosendahl
ReNeu: A Pivotal, Phase IIb Trial of Mirdametinib in Adults and Children With Symptomatic Neurofibromatosis Type 1-Associated Plexiform Neurofibroma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025 · 90 citations ·
Nigrostriatal tau pathology in parkinsonism and Parkinson's disease.
Brain : a journal of neurology · 2024 · 127 citations · Howard Federoff
Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a study.
The Lancet. Neurology · 2023 · 236 citations · Tahseen Mozaffar